Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$261M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$241M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$234M |
| 4 |
Keurig Dr Pepper
KDP
|
+$173M |
| 5 |
FedEx
FDX
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 7.18% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.3% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
PUT
Expedia Group
EXPE
$40.6B
| $9.06M | 0.01% |
+68,400
| New | +$7.71M |
|
|
ARA
1802
DELISTED
American Renal Associates Holdings, Inc
ARA
| $9.03M | 0.01% |
+788,488
| New | +$8.98M |
|
|
SKINW
1803
CALL
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
| $9.02M | 0.01% |
+797,183
| New | +$1.78M |
|
1804
Arbor Realty Trust
ABR
$961M
| $9.01M | 0.01% |
635,158
-353,072
| -36% | -$4.58M |
|
1805
CEMIG Preferred Shares
CIG
$5.78B
| $8.99M | 0.01% |
5,884,367
+4,838,840
| +463% | +$5.89M |
|
1806
Factset
FDS
$10.5B
| $8.98M | 0.01% |
27,018
+23,096
| +589% | +$7.63M |
|
1807
TechnipFMC
FTI
$29.5B
| $8.97M | 0.01% |
1,282,271
-1,913,154
| -60% | -$11.2M |
|
1808
CALL
T-Mobile US
TMUS
$195B
| $8.97M | 0.01% |
66,500
-47,300
| -42% | -$5.84M |
|
1809
CALL
Ascendis Pharma A/S
ASND
$16.6B
| $8.96M | 0.01% |
+53,700
| New | +$8.88M |
|
1810
Nice
NICE
$5.88B
| $8.95M | 0.01% |
31,568
-1,326
| -4% | -$322K |
|
1811
Vanguard Morningstar Total Stock Market ETF
VTI
$685B
| $8.95M | 0.01% |
45,956
+28,297
| +160% | +$5.17M |
|
1812
Stride
LRN
$3.56B
| $8.94M | 0.01% |
421,291
+215,738
| +105% | +$5.36M |
|
1813
Enviri
NVRI
$609M
| $8.94M | 0.01% |
497,270
+465,421
| +1,461% | +$7.48M |
|
|
ALTR
1814
DELISTED
Altair Engineering Inc
ALTR
| $8.93M | 0.01% |
153,437
+112,723
| +277% | +$5.68M |
|
|
AMRS
1815
DELISTED
Amyris Inc.
AMRS
| $8.92M | 0.01% |
1,444,997
+1,336,878
| +1,236% | +$4.27M |
|
|
ELMS
1816
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
| $8.92M | 0.01% |
658,779
-561,216
| -46% | -$6.03M |
|
1817
US Foods
USFD
$23.6B
| $8.91M | 0.01% |
267,611
-788,633
| -75% | -$22.5M |
|
|
HYZN
1818
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $8.9M | 0.01% |
+16,800
| New | +$8.78M |
|
1819
Tyler Technologies
TYL
$14.3B
| $8.9M | 0.01% |
20,393
+4,312
| +27% | +$1.78M |
|
1820
Turning Point Brands
TPB
$1.72B
| $8.9M | 0.01% |
199,760
+77,435
| +63% | +$2.93M |
|
|
PHICU
1821
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
| $8.9M | 0.01% |
+851,465
| New | +$8.77M |
|
1822
Amdocs
DOX
$6.51B
| $8.87M | 0.01% |
125,100
-147,698
| -54% | -$9.27M |
|
1823
Upbound Group
UPBD
$1.13B
| $8.87M | 0.01% |
231,725
+29,923
| +15% | +$1.02M |
|
|
RTP.U
1824
DELISTED
Reinvent Technology Partners Units, each consisting of one Class A ordinary share and one-fourth of
RTP.U
| $8.87M | 0.01% |
724,138
-2,750,000
| -79% | -$31.5M |
|
1825
PUT
Baidu
BIDU
$31.7B
| $8.87M | 0.01% |
41,000
+14,500
| +55% | +$2.15M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 71% from $81.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $41.4B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $261M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 71% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.